Elzasonan metabolite M4(1809097-10-6)
- Name: Elzasonan metabolite M4
- Synonyms:Elzasonan metabolite M4;EZ6KG9WG04;UNII-EZ6KG9WG04;(2Z)-4-(3,4-Dichlorophenyl)-2-((2-(1-piperazinyl)phenyl)methylene)-3-thiomorpholinone;3-Thiomorpholinone, 4-(3,4-dichlorophenyl)-2-((2-(1-piperazinyl)phenyl)methylene)-, (2Z)-;1809097-10-6;SCHEMBL5160053
- Molecular Formula:C21H21Cl2N3OS
- Molecular Weight:434.4
- CAS Registry Number:1809097-10-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1026449-27-3/1,2-Dimethyl-1,2-dihydro-3,4-pyridinedione
- 179474-62-5/Acetic acid, (2-(hydrazinoiminomethyl)hydrazino)-
- 156639-77-9/3-Epi-fagomine
- 444287-55-2/3-{1-Oxo-4-[benzylamino]isoindolin-2-yl}piperidine-2,6-dione
- 73255-41-1/4-(4'-O-Acetyl-alpha-L-rhamnosyloxy)benzyl isothiocyanate
- 365429-14-7/N-[4-[4-(3-Chlorophenyl)-2-ethyl-1,3-thiazol-5-YL]-2-pyridyl]acetamide
- 507479-60-9/tert-butyl N-[(3R)-7-bromo-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]carbamate
- 355387-25-6/2-((5,7-Dipropyl-3-(trifluoromethyl)-1,2-benzisoxazol-6-yl)oxy)-2-methylpropanoic acid
- 1202172-03-9/1-(2-Phenanthrenylcarbonyl)-2,3-piperazinedicarboxylic acid
- 1254710-01-4/Formoterol hydrochloride
- 452342-81-3/4-[3-(2-Pyridinyl)-1h-pyrazol-4-yl]-2-[4-(1-pyrrolidinylmethyl)phenyl]pyridine
- 496057-42-2/N-(2,3-Dihydro-2-oxo-1H-benzimidazol-5-yl)-4-[(4-fluorophenyl)methyl]-1-piperidineacetamide
- 409366-53-6/4-fluoro-N-(2,4,6,7-tetramethyl-3-phenyl-1-benzofuran-5-yl)benzamide
- 3606-43-7/O-Acetylchelidonine
- 353229-64-8/N-(3-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine
- 866602-91-7/3H-Furo(3,4-b)pyrano(4,3-E)pyridine-1,8(4H,7H)-dione, 5,9-dihydro-9-(3-iodo-4-methylphenyl)-, (9R)-
- 476322-72-2/3-{1-[4-(4-Bromo-3-methoxy-phenyl)-piperazin-1-yl]-ethyl}-quinoline
- 394223-04-2/(alphaR)-6-Methoxy-alpha-[[4-[(1H-pyrrolo[2,3-b]pyridin-2-ylmethyl)amino]-1-piperidinyl]methyl]-4-quinolinemethanol
- 779320-96-6/N-(2-((3-(4-(Aminomethyl)phenyl)propyl)amino)ethyl)-1-chloronaphthalene-2-sulfonamide
- 1809097-10-6/Elzasonan metabolite M4
- 949935-06-2/Sotrastaurin
- 375824-98-9/2,3,4-Trichloro-N-(5,5-dimethyl-7-oxo-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)benzenesulfonamide
- 365429-24-9/N-[4-[4-(3-Chlorophenyl)-2-[4-(methylthio)phenyl]-1,3-thiazol-5-YL]-2-pyridyl]propionamide
- 365429-61-4/N-[5-(2-Cyclohexylamino-4-pyridyl)-4-(3-methylphenyl)-1,3-thiazol-2-YL]nicotinamide
- 443955-57-5/6-[[[1-[(2R)-2-Hydroxy-2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]-4-piperidinyl]amino]methyl]-2H-1,4-benzothiazin-3(4H)-one
- 391209-56-6/5-Chloro-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)benzamide
- 359783-06-5/1-Propanone, 1-(3,4-dihydroxy-5-nitrophenyl)-3-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)-, dihydrochloride
- 377728-01-3/7-[2-[4-[2-Fluoro-4-(2-methoxyethoxy)phenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
- 303163-19-1/N-[4-[4-(3-Methylphenyl)-2-(4-methylsulfonylphenyl)-1,3-thiazol-5-YL]-2-pyridyl]benzamide
- 1026306-44-4/4-(7-Ethyl-2H-1,3-benzodioxol-5-yl)-1,1-dioxo-2-{[2-(trifluoromethyl)phenyl]methyl}-1,2-dihydro-1 lambda6,2-benzothiazine-3-carboxylic acid